BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 265 filers reported holding BIONTECH SE in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,189,158 | -0.1% | 38,560 | -0.8% | 0.08% | +1.2% |
| Q2 2023 | $4,194,053 | -14.6% | 38,860 | -1.4% | 0.08% | -25.9% |
| Q1 2023 | $4,911,367 | -0.3% | 39,430 | +20.3% | 0.11% | -1.8% |
| Q4 2022 | $4,925,919 | +4419.2% | 32,785 | +3972.7% | 0.11% | +3700.0% |
| Q3 2022 | $109,000 | -8.4% | 805 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $119,000 | -35.0% | 805 | -25.3% | 0.00% | -25.0% |
| Q1 2022 | $183,000 | -22.1% | 1,077 | +16.2% | 0.00% | -20.0% |
| Q4 2021 | $235,000 | +13.5% | 927 | +22.6% | 0.01% | 0.0% |
| Q3 2021 | $207,000 | +22.5% | 756 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $169,000 | +103.6% | 756 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $83,000 | +196.4% | 756 | +122.4% | 0.00% | +100.0% |
| Q4 2020 | $28,000 | – | 340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |